In embryonic development, Bone morphogenetic proteins (BMPs) promote endothelial specification and subsequent vascular differentiation. A subset of tissue-resident endothelial cells, referred to as endothelial stem/progenitor cells, have regenerative capacity in response to injury and are believed to retain phenotypic flexibility. Transplantation of such cells can represent a novel cell-based therapy for
vasculopathies.